3.9 Review

Neonatal Host Defense against Staphylococcal Infections

期刊

出版社

HINDAWI LTD
DOI: 10.1155/2013/826303

关键词

-

资金

  1. National Institutes of Health [R01-AI100135-01]
  2. Bill & Melinda Gates Foundation [OPPGH5284, OPP1035192]
  3. VentiRx Pharmaceuticals
  4. 3 M Drug Delivery Systems
  5. Mitacs-Accelerate Internship Program
  6. Bill and Melinda Gates Foundation [OPPGH5284, OPP1035192] Funding Source: Bill and Melinda Gates Foundation

向作者/读者索取更多资源

Preterm infants are especially susceptible to late-onset sepsis that is often due to Gram-positive bacterial infections resulting in substantial morbidity and mortality. Herein, we will describe neonatal innate immunity to Staphylococcus spp. comparing differences between preterm and full-term newborns with adults. Newborn innate immunity is distinct demonstrating diminished skin integrity, impaired Th1-polarizing responses, low complement levels, and diminished expression of plasma antimicrobial proteins and peptides, especially in preterm newborns. Characterization of distinct aspects of the neonatal immune response is defining novel approaches to enhance host defense to prevent and/or treat staphylococcal infection in this vulnerable population.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据